| PERIOD ENDING | 2-May-09 | 31-Jan-09 | 1-Nov-08 | 2-Aug-08 | | Total Revenue | 14,833,000 | 19,560,000 | 15,114,000 | 15,472,000 | | Cost of Revenue | 9,936,000 | 13,825,000 | 10,130,000 | 10,030,000 | | | Gross Profit | 4,897,000 | 5,735,000 | 4,984,000 | 5,442,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,399,000 | 4,104,000 | 3,649,000 | 3,773,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 472,000 | 474,000 | 468,000 | 449,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,026,000 | 1,157,000 | 867,000 | 1,220,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 130,000 | (121,000) | 29,000 | | Earnings Before Interest And Taxes | 1,027,000 | 1,287,000 | 746,000 | 1,249,000 | | Interest Expense | 203,000 | 344,000 | 114,000 | 245,000 | | Income Before Tax | 824,000 | 943,000 | 632,000 | 1,004,000 | | Income Tax Expense | 302,000 | 334,000 | 264,000 | 369,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 522,000 | 609,000 | 368,000 | 635,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 522,000 | 609,000 | 368,000 | 635,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $522,000 | $609,000 | $368,000 | $635,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
